Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 5 Issue 2

Pharmacological and Analytical Aspects of Esculetin: A Comprehensive Review

Manoj Gadewar*, Lakhveer Singh, Mohd Kafeel and Dharmender

Department of Pharmacology, School of Medical and Allied Sciences, K.R. Mangalam University, Gurugram, Haryana, India

*Corresponding Author: Manoj Gadewar, Professor, Department of Pharmacology, School of Medical and Allied Sciences, K.R. Mangalam University, Gurugram, Haryana, India.

Received: December 17, 2020; Published: January 28, 2021

×

Abstract

Plants have been used as a source of food material and natural remedies for the treatment of various ailments. Medicinal plants exhibit various pharmacological activities due to the presence of one or more phytoconstituents such as alkaloids, glycosides, flavonoids, terpenes etc. Coumarins (1, 2 benzopyrones) are a large group of naturally occurring secondary metabolites present in higher plants. Esculetin (6, 7-dihydroxycoumarin) is a coumarin derivative found in a plant, Cichorium intybus which is widely distributed in Europe and other parts of the world. It is also present in a Chinese plant, Bougainllra spectabillis and used as folk medicines. Although it is found in herbal medicines, exhibit various pharmacological actions such as antioxidant, hepatoprotective, anti-inflammatory, anticancer, hypoglycemic and chemopreventive action. Only limited scientific research has been published. The aim of this review is to collect all available scientific information which will provide valuable information to researchers in further development and screening methods for the treatment of various diseases by using esculetin as a potential molecule.

Keywords: Esculetin; Anti-inflammatory; Coumarins; Proliferative; Alkaloids; Saponinis

×

References

  1. Bruneton J. “Pharmacognosy, Phytochemistry, Medicinal Plants”. Second Edition, Hampshire UK, Intercept Ltd (1999): 263-277.
  2. Egan DO., et al. “The pharmacology, metabolism, analysis and applications of coumarin and coumarin related compounds”. Drug Metabolism Reviews 22 (1990): 503-529.
  3. Egan D., et al. “Rapid and Sensitive Determination of Coumarin and 7-hydroxycoumarin and its Glucuronide Conjugate in Urine and Plasma by High Performance Liquid Chromatography”. Journal of Chromatography B 582 (1992): 137-143.
  4. Finn G., et al. “In vitro cytotoxic potential and mechanism of action of selected coumarins using human renal cell lines”. Cancer Letters 183 (2002): 61-68.
  5. Lake B. “Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment”. Food and Chemical Toxicology 37 (1999): 423-453.
  6. Guilet D., et al. “Cytotoxic coumarins from Calophyllum dispar”. Phytochemistry 58 (2001): 571-575.
  7. Nadkarni A K. “Indian Materia Medica. Bombay: Popular Parkashan” (1976): 314.
  8. Chang W S., et al. “Superoxide anion scavenging effect of coumarins”. American Journal of Chinese Medicine 24 (1996): 11-17.
  9. Kim S H., et al. “Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species”. Acta Pharmacologica Sinica 29 (2008): 1319-1326.
  10. Tubaro A., et al. “Antiinflammatory and peripheral analgesic activity of esculetin in vivo”. Pharmacological Research Communications 20 (1998): 83-85.
  11. Paya M., et al. “Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals”. Biochemical Pharmacology 44 (1992): 205-214.
  12. Kaneko T., et al. “Suppression of lipid hydroperoxideinduced oxidative damage to cellular DNA by esculetin”. Biological and Pharmaceutical Bulletin 26 (2003): 840-844.
  13. Kuo H C., et al. “Enhancement of esculetin on taxol-induced apoptosis inhumanhepatoma HepG2 cells”. Toxicology and Applied Pharmacology 210 (2006): 55-62.
  14. Kok S H., et al. “Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells”. Oral Oncology (2009): 7-18.
  15. Leung K N., et al. “Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on murine lymphocytes and peritoneal macrophages”. Molecular Immunology 2 (2005): 181-188.
  16. Egan D and O’Kennedy R. “Rapid and Sensitive Determination of Coumarin and 7-hydroxycoumarin and its Glucuronide Conjugate in Urine and Plasma by High Performance Liquid Chromatography”. Journal of Chromatography B 582 (1992): 137-143.
  17. Lin WL., et al. “Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver”. Archives of Toxicology 74 (2000): 467-472.
  18. Neichi T., et al. “Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis”. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 753 (1983): 130-132.
  19. Yun E S., et al. “MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation”. Toxicology in Vitro 25 (2011): 1335-1342.
  20. Yue Y., et al. “Study of the interaction between esculetin and human serum albumin by multi-spectroscopic method and molecular modeling”. Journal of Molecular Structure 888 (2008): 25-32.
  21. Chua C., et al. “Induction of apoptosis by esculetin in human leukemia cells”. European Journal of Pharmacology 416 (2001): 25-32.
  22. Anand J R., et al. “Anticancer activity of esculetin via-modulation of Bcl-2 and NF-kB expression in benzo[a]pyrene induced lung carcinogenesis in mice”. Biomedicine and Preventive Nutrition 3 (2013): 107-112.
  23. Subramaniam S R and Ellis E M. “Esculetin-induced protection of human hepatoma HepG2 cells against hydrogen peroxide is associated with the Nrf2-dependent induction of the NAD (P)H: Quinone oxidoreductase 1 gene”. Toxicology and Applied Pharmacology 250 (2011): 130-136.
  24. Dhamodaran P and Ashokkumar N. “Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats”. Biochimie 95 (2013): 366-373.
  25. Gilani H., et al. “Esculetin prevents liver damage induced by Paracetamol and CCl4”. Pharmacology Research 37 (1998): 31-35.
  26. Pan SL., et al. “Esculetin Inhibits Rasmediated Cell Proliferation and Alleviates Vascular Restenosis Following Angioplasty in Rats”. Biochemical Pharmacology 65 (2003): 1897-1905.
  27. Ritschel W A., et al. “Biopharmaceutical Parameters of Coumarin and 7-hydroxycoumarin”. Die Pharmazeutische Industrie 43 (1981): 271-276.
×

Citation

Citation: Manoj Gadewar., et al. “Pharmacological and Analytical Aspects of Esculetin: A Comprehensive Review”.Acta Scientific Medical Sciences 5.2 (2021): 105-110.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor0.851

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US